$TDOC

Nueno Carlos sold $39K of TDOC

Nueno Carlos (President, International) sold 6,200 shares of Teladoc Health, Inc. (TDOC) at $6.30 on 2026-09-02.

Original reporting
SEC EDGAR · Nueno Carlos
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
high confidence
Mentioned
$TDOC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The disclosed sale is modest and does not alter the fundamental outlook for Teladoc Health.

02

Market read

Limited relevance; typical insider sell with minimal market impact.

03

What to watch

Potential upcoming strategic changes not disclosed; however, no public indication exists.

Relevance 3/10Novelty 6/10Timing: sale reported on 2026-09-02, filed 2026-09-03

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of confidence or concern.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

President of International sold 6,200 shares for $39K, reducing his stake to 64,744 shares.

Expected impact

No significant price change expected.

Evidence & confidence

The sale size is small relative to market cap and typical insider activity; market participants usually ignore such modest disposals.

Market effects

No broader impact on the telehealth sector.

No regional effect; transaction is company‑specific.

Not relevant to global markets.

Counterpoint

If the insider is reallocating capital, it could signal confidence in other opportunities, but the amount is too small to infer.

Key entities

  • Teladoc Health, Inc.

    US‑listed telehealth provider (NASDAQ:TDOC).

  • Nueno Carlos

    President, International at Teladoc Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.